XML 132 R51.htm IDEA: XBRL DOCUMENT v2.4.0.6
STOCK-BASED COMPENSATION (Tables)
12 Months Ended
Dec. 31, 2012
STOCK-BASED COMPENSATION  
Schedule of performance shares awarded and estimated fair value of the awards at grant date

 

Year
Awarded
  Performance
Shares
  Estimated
Fair Value
 
 
   
  (Dollars In
Thousands)

 

2012

    306,100   $ 8,608  

2011

    191,100     5,433  

2010

         
Schedule of the SARs activity as well as weighted-average base price

 

 
  Weighted-Average
Base Price per share
  No. of SARs    

Balance at December 31, 2009

  $ 22.28     2,469,202    
             

SARs granted

    18.34     344,400    

SARs exercised / forfeited

    20.98     (488,765 )  
             

Balance at December 31, 2010

  $ 21.97     2,324,837    
             

SARs exercised / forfeited

    8.31     (50,608 )  
             

Balance at December 31, 2011

    22.27     2,274,229    
             

SARs exercised / forfeited / expired

    22.60     (633,062 )  
             

Balance at December 31, 2012

  $ 22.15     1,641,167    
             
Schedule of equity compensation plans

 

Plan category
  Number of securities
to be issued upon
exercise of
outstanding options,
warrants and rights as
of December 31, 2012 (a)
  Weighted-average
exercise price of
outstanding options,
warrants and rights as
of December 31, 2012 (b)
  Number of securities
remaining available
for future issuance
under equity
compensation plans
(excluding securities
reflected in
column (a)) as of
of December 31, 2012 (c)
   

Equity compensation plans approved by shareowners

    2,702,768 (1) $ 22.15 (3)   4,530,673 (4)  

Equity compensation plans not approved by shareowners

    318,421 (2)   Not applicable     Not applicable (5)  
                 

Total

    3,021,189   $ 22.15     4,530,673    
                 
(1)
Includes the following number of shares: (a) 1,066,759 shares issuable with respect to outstanding SARs (assuming for this purpose that one share of common stock will be payable with respect to each outstanding SAR); (b) 602,160 shares issuable with respect to outstanding performance share awards (assuming for this purpose that the awards are payable based on estimated performance under the awards as of September 30, 2012); (c) 646,632 shares issuable with respect to outstanding restricted stock units (assuming for this purpose that shares will be payable with respect to all outstanding restricted stock units); (d) 319,555 shares issuable with respect to stock equivalents representing previously earned awards under the LTIP that the recipient deferred under the Company's Deferred Compensation Plan for Officers; and (e) 67,662 shares issuable with respect to stock equivalents representing previous awards under the Company's Stock Plan for Non-Employee Directors that the recipient deferred under our Deferred Compensation Plan for Directors Who Are Not Employees of the Company.

(2)
Includes the following number of shares of common stock: (a) 216,103 shares issuable with respect to stock equivalents representing (i) stock awards to the Company's Directors before June 1, 2004 that the recipient deferred pursuant to the Company's Deferred Compensation Plan for Directors Who Are Not Employees of the Company and (ii) cash retainers and fees that the Company's Directors deferred under the Company's Deferred Compensation Plan for Directors Who Are Not Employees of the Company, and (b) 102,318 shares issuable with respect to stock equivalents pursuant to the Company's Deferred Compensation Plan for Officers.

(3)
Based on exercise prices of outstanding SARs.

(4)
Represents shares of common stock available for future issuance under the LTIP and the Company's Stock Plan for Non-Employee Directors.

(5)
The plans listed in Note (2) do not currently have limits on the number of shares of common stock issuable under such plans. The total number of shares of common stock that may be issuable under such plans will depend upon, among other factors, the deferral elections made by the plans' participants.
Schedule of outstanding SARs by base prices

The outstanding SARs as of December 31, 2012, were at the following base prices:

Base Price
  SARs
Outstanding
  Remaining Life
in Years
  Currently
Exercisable
 

$26.49

    50,000     1     50,000  

$41.05

    106,700     3     106,700  

$48.60

    38,400     4     38,400  

$45.70

    35,070     4     35,070  

$43.46

    181,550     5     181,550  

$48.05

    3,000     5     3,000  

$41.12

    2,500     5     2,500  

$38.59

    303,100     6     303,100  

$3.50

    629,608     7     629,608  

$17.48

    8,000     8     5,333  

$18.36

    283,239     8     181,888